Literature DB >> 33601056

WDR5 facilitates EMT and metastasis of CCA by increasing HIF-1α accumulation in Myc-dependent and independent pathways.

Tianli Chen1, Kangshuai Li1, Zengli Liu1, Jialiang Liu1, Yue Wang1, Rongqi Sun1, Zhipeng Li2, Bo Qiu1, Xiaoming Zhang3, Guangli Ren4, Yunfei Xu5, Zongli Zhang6.   

Abstract

Cholangiocarcinoma (CCA) is a highly aggressive malignancy with extremely poor prognoses. The oncogenic role and prognostic value of c-Myc in CCA is not well elucidated. WD repeat domain 5 (WDR5) is a critical regulatory factor directly interacting with c-Myc to regulate c-Myc recruitment at chromosomal locations, but the interaction of WDR5 and c-Myc in CCA was uncovered. In our study, we detected WDR5 and c-Myc expression in all CCA types, including intrahepatic (iCCA), perihilar (pCCA), and distal (dCCA) CCA, and evaluated their prognostic significance. Consequently, we demonstrated that WDR5 was significantly correlated with poor prognosis of CCA and that WDR5 and c-Myc co-expression was a more sensitive prognostic factor. With in vitro and in vivo experiments and bioinformatics, we showed that WDR5 interacted with the Myc box IIIb (MBIIIb) motif of c-Myc and facilitated Myc-induced HIF1A transcription, thereby promoting the epithelial-mesenchymal transition (EMT), invasion, and metastasis of CCA. Moreover, WDR5 enhanced hypoxia-inducible factor 1 subunit α (HIF-1α) accumulation by binding with histone deacetylase 2 (HDAC2) and increasing histone 3 lysine 4 acetylation (H3K4ac) deacetylation of the prolyl hydroxylase domain protein 2 (PHD2) promoter, resulting in the attenuation of chromatin opening and PHD2 expression, and eventually leading to HIF-1α stabilization and accumulation. In conclusion, WDR5 facilitated EMT and metastasis of CCA by increasing HIF-1α accumulation in a Myc-dependent pathway to promote HIF-1α transcription and a Myc-independent pathway to stabilize HIF-1α.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Keywords:  CCA; EMT; HIF-1α; PHD2; WDR5; c-Myc

Mesh:

Substances:

Year:  2021        PMID: 33601056      PMCID: PMC8178527          DOI: 10.1016/j.ymthe.2021.02.017

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   12.910


  58 in total

1.  BET bromodomain inhibition as a therapeutic strategy to target c-Myc.

Authors:  Jake E Delmore; Ghayas C Issa; Madeleine E Lemieux; Peter B Rahl; Junwei Shi; Hannah M Jacobs; Efstathios Kastritis; Timothy Gilpatrick; Ronald M Paranal; Jun Qi; Marta Chesi; Anna C Schinzel; Michael R McKeown; Timothy P Heffernan; Christopher R Vakoc; P Leif Bergsagel; Irene M Ghobrial; Paul G Richardson; Richard A Young; William C Hahn; Kenneth C Anderson; Andrew L Kung; James E Bradner; Constantine S Mitsiades
Journal:  Cell       Date:  2011-09-01       Impact factor: 41.582

2.  In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer.

Authors:  Alessandro Carugo; Giannicola Genovese; Sahil Seth; Luigi Nezi; Johnathon Lynn Rose; Daniela Bossi; Angelo Cicalese; Parantu Krushnakant Shah; Andrea Viale; Piergiorgio Francesco Pettazzoni; Kadir Caner Akdemir; Christopher Aaron Bristow; Frederick Scott Robinson; James Tepper; Nora Sanchez; Sonal Gupta; Marcos Roberto Estecio; Virginia Giuliani; Gaetano Ivan Dellino; Laura Riva; Wantong Yao; Maria Emilia Di Francesco; Tessa Green; Carolina D'Alesio; Denise Corti; Ya'an Kang; Philip Jones; Huamin Wang; Jason Bates Fleming; Anirban Maitra; Pier Giuseppe Pelicci; Lynda Chin; Ronald Anthony DePinho; Luisa Lanfrancone; Timothy Paul Heffernan; Giulio Francesco Draetta
Journal:  Cell Rep       Date:  2016-06-16       Impact factor: 9.423

3.  C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation.

Authors:  A C Epstein; J M Gleadle; L A McNeill; K S Hewitson; J O'Rourke; D R Mole; M Mukherji; E Metzen; M I Wilson; A Dhanda; Y M Tian; N Masson; D L Hamilton; P Jaakkola; R Barstead; J Hodgkin; P H Maxwell; C W Pugh; C J Schofield; P J Ratcliffe
Journal:  Cell       Date:  2001-10-05       Impact factor: 41.582

4.  HIF-1α promotes autophagic proteolysis of Dicer and enhances tumor metastasis.

Authors:  Hui-Huang Lai; Jie-Ning Li; Ming-Yang Wang; Hsin-Yi Huang; Carlo M Croce; Hui-Lung Sun; Yu-Jhen Lyu; Jui-Wen Kang; Ching-Feng Chiu; Mien-Chie Hung; Hiroshi I Suzuki; Pai-Sheng Chen
Journal:  J Clin Invest       Date:  2017-12-18       Impact factor: 14.808

Review 5.  The c-Myc target gene network.

Authors:  Chi V Dang; Kathryn A O'Donnell; Karen I Zeller; Tam Nguyen; Rebecca C Osthus; Feng Li
Journal:  Semin Cancer Biol       Date:  2006-07-25       Impact factor: 15.707

Review 6.  Cholangiocarcinoma.

Authors:  Nataliya Razumilava; Gregory J Gores
Journal:  Lancet       Date:  2014-02-26       Impact factor: 79.321

7.  Hypoxia-inducible factor-1alpha induces Twist expression in tubular epithelial cells subjected to hypoxia, leading to epithelial-to-mesenchymal transition.

Authors:  Shiren Sun; Xiaoxuan Ning; Yanqi Zhang; Yuanyuan Lu; Yongzhan Nie; Shuang Han; Lili Liu; Rui Du; Lin Xia; Lijie He; Daiming Fan
Journal:  Kidney Int       Date:  2009-03-11       Impact factor: 10.612

8.  Efficient low-cost chromatin profiling with CUT&Tag.

Authors:  Hatice S Kaya-Okur; Derek H Janssens; Jorja G Henikoff; Kami Ahmad; Steven Henikoff
Journal:  Nat Protoc       Date:  2020-09-10       Impact factor: 13.491

Review 9.  Targeting HIF-1 for cancer therapy.

Authors:  Gregg L Semenza
Journal:  Nat Rev Cancer       Date:  2003-10       Impact factor: 60.716

10.  Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression.

Authors:  Johannes Schödel; Chiara Bardella; Lina K Sciesielski; Jill M Brown; Chris W Pugh; Veronica Buckle; Ian P Tomlinson; Peter J Ratcliffe; David R Mole
Journal:  Nat Genet       Date:  2012-03-11       Impact factor: 38.330

View more
  10 in total

1.  GPBAR1 promotes proliferation and is related to poor prognosis of high-grade glioma via inducing MAFB expression.

Authors:  Suohui Sun; Hui Guo; Nan Liang; Tao Wu; Chunpu Zhang; Huaqing Li
Journal:  Histol Histopathol       Date:  2021-12-14       Impact factor: 2.303

2.  BMI1 promotes cholangiocarcinoma progression and correlates with antitumor immunity in an exosome-dependent manner.

Authors:  Zengli Liu; Chunxiao Hu; Lijie Zheng; Jialiang Liu; Kangshuai Li; Xingyong Li; Yue Wang; Wentao Mu; Tianli Chen; Anda Shi; Bo Qiu; Xin Zhang; Zongli Zhang; Yunfei Xu
Journal:  Cell Mol Life Sci       Date:  2022-08-06       Impact factor: 9.207

3.  Human umbilical cord mesenchymal stem cell-derived extracellular vesicles carrying miR-655-3p inhibit the development of esophageal cancer by regulating the expression of HIF-1α via a LMO4/HDAC2-dependent mechanism.

Authors:  Mingjiu Chen; Zhenkun Xia; Jie Deng
Journal:  Cell Biol Toxicol       Date:  2022-10-12       Impact factor: 6.819

4.  The Smad4-MYO18A-PP1A complex regulates β-catenin phosphorylation and pemigatinib resistance by inhibiting PAK1 in cholangiocarcinoma.

Authors:  Jialiang Liu; Guangli Ren; Kangshuai Li; Zengli Liu; Yue Wang; Tianli Chen; Wentao Mu; Xiaoqing Yang; Xingyong Li; Anda Shi; Wei Zhao; Bowen Xu; Jianhua Chang; Sen Guo; Chang Pan; Tao Zhou; Zongli Zhang; Yunfei Xu
Journal:  Cell Death Differ       Date:  2021-11-19       Impact factor: 12.067

5.  Dual-Specificity Phosphatase 11 Is a Prognostic Biomarker of Intrahepatic Cholangiocarcinoma.

Authors:  Lin Xu; Peng Wang; Wei Zhang; Weiran Li; Tao Liu; Xu Che
Journal:  Front Oncol       Date:  2021-09-29       Impact factor: 6.244

6.  Aldehyde dehydrogenase 3B2 promotes the proliferation and invasion of cholangiocarcinoma by increasing Integrin Beta 1 expression.

Authors:  Yue Wang; Kangshuai Li; Wei Zhao; Zengli Liu; Jialiang Liu; Anda Shi; Tianli Chen; Wentao Mu; Yunfei Xu; Chang Pan; Zongli Zhang
Journal:  Cell Death Dis       Date:  2021-12-14       Impact factor: 8.469

7.  Interaction Between Macrophage Extracellular Traps and Colon Cancer Cells Promotes Colon Cancer Invasion and Correlates With Unfavorable Prognosis.

Authors:  Tianli Chen; Yue Wang; Zhaodi Nan; Jie Wu; Ailu Li; Tingguo Zhang; Xun Qu; Chen Li
Journal:  Front Immunol       Date:  2021-12-01       Impact factor: 7.561

8.  The expression, clinical relevance, and prognostic significance of HJURP in cholangiocarcinoma.

Authors:  Yang Yang; Jinyan Yuan; Zhenzhong Liu; Wenwen Cao; Pei Liu
Journal:  Front Oncol       Date:  2022-07-28       Impact factor: 5.738

9.  ZFAND5 Is an Independent Prognostic Biomarker of Perihilar Cholangiocarcinoma.

Authors:  Pei Liu; Yijia Wang; Lingling Duan
Journal:  Front Oncol       Date:  2022-07-13       Impact factor: 5.738

10.  WDR5 is a prognostic biomarker of brain metastasis from non-small cell lung cancer.

Authors:  Zheng Li; Nan Liang; Na Wang; Yan Jia; Cui Tian
Journal:  Front Oncol       Date:  2022-09-29       Impact factor: 5.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.